Botanix Pharmaceuticals Limited (BXPHF)
OTCMKTS · Delayed Price · Currency is USD
0.0883
0.00 (0.00%)
Feb 11, 2026, 9:30 AM EST

Botanix Pharmaceuticals Balance Sheet

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Equivalents
64.9779.3110.257.2921.55
Cash & Short-Term Investments
64.9779.3110.257.2921.55
Cash Growth
-18.08%673.71%40.69%-66.20%-12.54%
Accounts Receivable
2.850.460.4--
Other Receivables
0.350.360.090.140.05
Receivables
3.20.820.490.140.05
Inventory
28.081.213.153.04-
Prepaid Expenses
3.340.10.090.030.01
Other Current Assets
-1.47---
Total Current Assets
99.5982.913.9810.521.61
Property, Plant & Equipment
1.380.070.070.180.28
Other Intangible Assets
28.1229.496.863.3-
Long-Term Deferred Charges
--3.87--
Other Long-Term Assets
--0.060.060.06
Total Assets
129.1112.4624.8414.0421.95
Accounts Payable
8.872.731.394.680.65
Accrued Expenses
3.940.560.150.10.09
Current Portion of Leases
0.41--0.120.15
Other Current Liabilities
11.70.440.340.990.15
Total Current Liabilities
24.923.731.885.891.04
Long-Term Leases
0.81---0.11
Other Long-Term Liabilities
22.07----
Total Liabilities
47.83.731.885.891.15
Common Stock
226.3188.3293.4971.4871.48
Retained Earnings
-177.19-90.79-76.92-67.77-54.6
Comprehensive Income & Other
32.1811.26.384.443.92
Shareholders' Equity
81.3108.7322.958.1520.8
Total Liabilities & Equity
129.1112.4624.8414.0421.95
Total Debt
1.22--0.120.26
Net Cash (Debt)
63.7579.3110.257.1621.3
Net Cash Growth
-19.62%673.71%43.10%-66.36%-12.09%
Net Cash Per Share
0.030.050.010.010.02
Filing Date Shares Outstanding
1,9611,8141,4211,085973.14
Total Common Shares Outstanding
1,9611,8101,312973.14973.14
Working Capital
74.6779.1712.094.6220.57
Book Value Per Share
0.040.060.020.010.02
Tangible Book Value
53.1779.2416.14.8620.8
Tangible Book Value Per Share
0.030.040.010.000.02
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.